EpiQMAx (Exit)

EpiQMAx combines epigenetic analyses with AI to offer digital testing solutions for molecular lifestyle assessment.

EpiQMAx (Exit) is a company in deeptech.

The company sits in the deeptech segment, where it competes on its core product or service.

It is recorded at the UnternehmerTUM Accelerator portfolio company stage.

Website: www.epiqmax.com